NYSE · Healthcare
HUMANA INC (HUM)
As-reported financials and recent SEC filings for HUMANA INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$129.66B
Net income
$1.19B
Net margin
0.9%
Diluted EPS
$9.84
ROE
6.7%
P/E (TTM)
40.5×
Market cap
$45.53B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Gross profit | — | — | — | — | — |
| Operating income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B |
| Net income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| Diluted EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-01
View on EDGAR →8-K2026-05-19
View on EDGAR →SCHEDULE 13G/A2026-05-14
View on EDGAR →42026-05-05
View on EDGAR →42026-05-05
View on EDGAR →42026-05-05
View on EDGAR →42026-05-05
View on EDGAR →42026-05-05
View on EDGAR →Go deeper on HUM
Search HUMANA INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.